The Lys207Gln mutation of human beta-cardiac Myosin Heavy Chain

(other names:  K207Q)

SEQUENCE
exon 7
nucleotide change A>C
nucleotide pos. in gene 7669
UCSC Golden Path position 22970830
amino acid changeLys>Gln
charge change -1
codon change AAG>CAG
transcript change missense
translation change  


mutated amplimer sequence:
cttgctggtctccagtagtattgttcactgcccaataagcccctgtcttc
acagcggagaatccggagcagggaagacagtcaacaccaagagggtcatc
cagtactttgctgttattgcagccattggggaccgcagcaagCaggacca
gagcccgggcaaggtaggcctgctgccctccaaggtcctgtaccgcag


RESTRICTION ENZYME
no information

 
disease HCM

 
    References and comments
  1. Mohiddin SA, Begley DA, McLam E, Cardoso JP, Winkler JB, Sellers JR, Fananapazir L.
    Utility of genetic screening in hypertrophic cardiomyopathy: prevalence and significance of novel and double (homozygous and heterozygous) beta-myosin mutations.
    Genet Test 2003 Spring;7(1):21-7. (PubMed:12820698)
  2. Alpert NR, Mohiddin SA, Tripodi D, Jacobson-Hatzell J, Vaughn-Whitley K, Brosseau C, Warshaw DM, Fananapazir L.
    Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations.
    Am J Physiol Heart Circ Physiol 2005 Mar;288(3):H1097-102. Epub 2004 Nov 4. (PubMed:15528230)
 

Last modified: April 24, 2006